Ascendis Pharma Market Sentiment

Ascendis Pharma AS

ASNDNASDAQ

Trade with Public

$252.99

1.040.41%

가까이에: Aug 25, 5:00 PM EST

$252.99

N/A

시간외: 7:13 PM EST

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Ascendis Pharma Market Sentiment

Market sentiment signals for Ascendis Pharma (ASND): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 6.2% short float

Options Flow▼ 8.07 P/C ratio

Insider Activity▲ Net Buyer (30d)

Analyst Consensus

Buy

22 analysts

Options Flow (P/C)

8.07

More puts — Bearish

30 calls · 242 puts

Avg Consensus PT

$287

+13.3%

Highest Price Target

$355

+40.3%

Citigroup

Lowest Price Target

$181

-28.5%

Wedbush

Short Interest

6.2%

Rising — Bearish

Insider Activity (30d)

Net Buyer

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 19, 2026	BMO Capital	David Lebowitz—	+26.1%	$319	Initiate	Outperform
Aug 14, 2026	TD Cowen	Yaron Werber—	+34.8%	$325 → $341	Maintained	Buy
Aug 14, 2026	RBC Capital	Luca Issi—	+14.6%	$280 → $290	Maintained	Outperform
Aug 14, 2026	Barclays	Eliana Merle—	+30.0%	$345 → $329	Maintained	Overweight
Jul 23, 2026	Morgan Stanley	Maxwell Skor—	+8.7%	$256 → $275	Maintained	Overweight
Jul 7, 2026	RBC Capital	Luca Issi—	+10.7%	$275 → $280	Maintained	Outperform
May 19, 2026	Citigroup	Eric Joseph—	+40.3%	$355	Initiate	Buy
May 15, 2026	Evercore ISI Group	Josh Schimmer—	+30.0%	$324 → $329	Maintained	Outperform
May 11, 2026	Barclays	Eliana Merle—	+36.4%	$342 → $345	Maintained	Overweight
May 8, 2026	Wells Fargo	Derek Archila—	+28.9%	$330 → $326	Maintained	Overweight
Apr 16, 2026	B of A Securities	Tazeen Ahmad—	+15.4%	$262 → $292	Maintained	Buy
Apr 9, 2026	Wedbush	Yun Zhong—	+7.9%	$273 → $273	Maintained	Outperform
Mar 16, 2026	Jefferies	Kelly Shi—	+14.6%	$290	Assumes	Buy
Mar 3, 2026	RBC Capital	Luca Issi—	+8.7%	$250 → $275	Maintained	Outperform
Feb 12, 2026	Oppenheimer	Leland Gershell—	+3.6%	$246 → $262	Maintained	Outperform
Feb 12, 2026	Wedbush	Yun Zhong—	+7.9%	$240 → $273	Maintained	Outperform
Jan 30, 2026	B of A Securities	Tazeen Ahmad—	+2.8%	$246 → $260	Maintained	Buy
Jan 28, 2026	Barclays	Eliana Merle—	+35.2%	$342	Initiate	Overweight
Jan 20, 2026	RBC Capital	Luca Issi—	-1.2%	$245 → $250	Maintained	Outperform
Jan 20, 2026	Wells Fargo	Derek Archila—	+30.4%	$322 → $330	Maintained	Overweight
Jan 9, 2026	Wells Fargo	Derek Archila—	+27.3%	$297 → $322	Maintained	Overweight
Jan 7, 2026	TD Cowen	Yaron Weber—	+28.5%	$325 → $325	Maintained	Buy
Dec 11, 2025	Stifel	Alex Thompson—	+1.2%	$254 → $256	Maintained	Buy
Nov 18, 2025	Wedbush	Yun Zhong—	-13.0%	$220 → $220	Maintained	Outperform
Oct 17, 2025	Raymond James	Martin Auster—	+7.1%	$271	Initiate	Strong Buy